Gary Ko

2.2k total citations
51 papers, 1.6k citations indexed

About

Gary Ko is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Gary Ko has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Gary Ko's work include Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Liver Disease Diagnosis and Treatment (8 papers) and Diabetes Treatment and Management (8 papers). Gary Ko is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Liver Disease Diagnosis and Treatment (8 papers) and Diabetes Treatment and Management (8 papers). Gary Ko collaborates with scholars based in Hong Kong, China and Canada. Gary Ko's co-authors include Juliana C.N. Chan, Clive S. Cockram, Ronald C.W., Xilin Yang, Alice P.S. Kong, Julia Critchley, Wing‐Yee So, Risa Ozaki, Peter C.Y. Tong and Chi Hung To and has published in prestigious journals such as Diabetes Care, PEDIATRICS and Cancer.

In The Last Decade

Gary Ko

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Ko Hong Kong 23 559 390 265 265 262 51 1.6k
Peter C.Y. Tong Hong Kong 25 847 1.5× 302 0.8× 312 1.2× 201 0.8× 314 1.2× 38 2.0k
Oleg Tsuprykov Germany 22 403 0.7× 216 0.6× 150 0.6× 174 0.7× 121 0.5× 33 1.2k
Ole Torffvit Sweden 30 584 1.0× 318 0.8× 235 0.9× 223 0.8× 332 1.3× 96 2.1k
Samy Hadjadj France 31 1.4k 2.6× 597 1.5× 668 2.5× 237 0.9× 638 2.4× 159 2.9k
Sydney Benchetrit Israel 18 185 0.3× 256 0.7× 158 0.6× 95 0.4× 245 0.9× 89 1.4k
Andrea Zuckerman United States 18 832 1.5× 248 0.6× 790 3.0× 66 0.2× 622 2.4× 32 2.4k
Erik Ingelsson Sweden 14 714 1.3× 141 0.4× 406 1.5× 78 0.3× 453 1.7× 20 1.7k
Yasue Omori Japan 27 1.1k 2.0× 609 1.6× 924 3.5× 333 1.3× 318 1.2× 102 2.7k
Göran Fex Sweden 26 397 0.7× 731 1.9× 290 1.1× 109 0.4× 100 0.4× 89 2.1k
Yong‐Ki Min South Korea 25 955 1.7× 449 1.2× 677 2.6× 64 0.2× 174 0.7× 101 2.0k

Countries citing papers authored by Gary Ko

Since Specialization
Citations

This map shows the geographic impact of Gary Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Ko more than expected).

Fields of papers citing papers by Gary Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Ko. The network helps show where Gary Ko may publish in the future.

Co-authorship network of co-authors of Gary Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Ko. A scholar is included among the top collaborators of Gary Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Ko. Gary Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ko, Gary, et al.. (2025). Multidisciplinary Oncology Education Among Postgraduate Trainees: Systematic Review. JMIR Medical Education. 11. e63655–e63655.
2.
Ko, Gary, Lucas C. Godoy, Cynthia A. Jackevicius, et al.. (2025). Text messaging interventions are associated with reductions in HbA1c among patients with diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Research & Care. 13(6). e005218–e005218.
3.
Alikhassi, Afsaneh, Anita Bane, Erin Cordeiro, et al.. (2025). Canadian Recommendations on Optimal Breast Biopsy Practices Developed Using a Modified Delphi Panel. Canadian Association of Radiologists Journal. 76(4). 705–719. 1 indexed citations
4.
Ko, Gary, et al.. (2024). The Impact of COVID-19 on Breast Cancer Care: A Qualitative Analysis of Surgeons’ Perspectives. Clinical Breast Cancer. 24(6). 494–500.e1. 1 indexed citations
5.
Ko, Gary, Julie Hallet, Katarzyna J. Jerzak, et al.. (2022). Low Rates of Medical Oncology Consultation for Older Women (≥ 70 Years) with Newly Diagnosed, Non-Metastatic Breast Cancer: A Population-Based Study. Annals of Surgical Oncology. 30(2). 1054–1062. 2 indexed citations
6.
Dang, Frances, Peter L. Wang, Gary Ko, et al.. (2021). Objective Structured Assessment of technical skill (OSATS) in the Surgical Skills and Technology Elective Program (SSTEP): Comparison of peer and expert raters. The American Journal of Surgery. 223(2). 276–279. 15 indexed citations
7.
Angarita, Fernando A., et al.. (2021). Why Do Older Women Avoid Breast Cancer Surgery? A Qualitative Analysis of Decision-Making Factors. Journal of Surgical Research. 268. 623–633. 8 indexed citations
8.
Kong, Alice P.S., Akira Yamasaki, Risa Ozaki, et al.. (2011). A randomized‐controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose–lipid control in type 2 diabetes. Diabetes Obesity and Metabolism. 13(9). 806–813. 15 indexed citations
9.
Yang, Xilin, Ronald C.W., Wing Yee So, et al.. (2010). Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus. Cancer. 117(4). 862–871. 22 indexed citations
10.
Yang, Xilin, Wing Yee So, Ronald C.W., et al.. (2010). Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry. Diabetes Research and Clinical Practice. 90(3). 343–351. 71 indexed citations
11.
Mok, Chi Chiu, et al.. (2010). Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care & Research. 63(2). 195–202. 152 indexed citations
12.
Yang, Xilin, Ronald C.W., Wing Yee So, et al.. (2009). White blood cell count and renin–angiotensin system inhibitors for the risk of cancer in type 2 diabetes. Diabetes Research and Clinical Practice. 87(1). 117–125. 13 indexed citations
13.
Tong, Peter C.Y., Gary Ko, Wing‐Yee So, et al.. (2008). Use of anti-diabetic drugs and glycaemic control in type 2 diabetes—The Hong Kong Diabetes Registry. Diabetes Research and Clinical Practice. 82(3). 346–352. 44 indexed citations
14.
Ko, Gary, Clive S. Cockram, Chun‐Chung Chow, et al.. (2004). Effects of body mass index, plasma glucose and cholesterol levels on isolated systolic hypertension. International Journal of Cardiology. 101(3). 429–433. 12 indexed citations
15.
Ko, Gary, Clive S. Cockram, Julia Critchley, & Juliana C.N. Chan. (2001). Glycaemic control and obesity are the major determinants of diabetic dyslipidaemia in Hong Kong Chinese.. PubMed. 27(6). 637–44. 7 indexed citations
16.
Ko, Gary, Hock Chuan Chan, & Chung‐Hung Chan. (2001). Blood pressure reduction and tolerability of amlodipine versus nifedipine retard in Chinese patients with Type 2 diabetes mellitus and hypertension: a randomized 1-year clinical trial. International Journal of Clinical Pharmacology and Therapeutics. 39(8). 331–335. 4 indexed citations
17.
Hashim, Y, J. K. Y. Li, Gary Ko, et al.. (2001). The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: Evidence for associations with type 2 diabetes and cholesterol levels. Clinical Endocrinology. 54(4). 541–546. 47 indexed citations
18.
Chan, Juliana C.N., Gary Ko, Denis H. Y. Leung, et al.. (2000). Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Kidney International. 57(2). 590–600. 144 indexed citations
19.
Chow, C. C., V.T.F. Yeung, Tony W.L. Mak, et al.. (2000). Treatment of Chinese acromegaly with a combination of bromocriptine and octreotide. Australian and New Zealand Journal of Medicine. 30(4). 457–461. 9 indexed citations
20.
Au, W.Y., et al.. (2000). Acute leukaemia in acromegaly patients. British Journal of Haematology. 110(4). 871–873. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter C.Y. Tong Breakdown of academic impact, for papers by Oleg Tsuprykov Breakdown of academic impact, for papers by Ole Torffvit Breakdown of academic impact, for papers by Samy Hadjadj Breakdown of academic impact, for papers by Sydney Benchetrit Breakdown of academic impact, for papers by Andrea Zuckerman Breakdown of academic impact, for papers by Erik Ingelsson Breakdown of academic impact, for papers by Yasue Omori Breakdown of academic impact, for papers by Göran Fex Breakdown of academic impact, for papers by Yong‐Ki Min
Rankless by CCL
2026